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Abstract. Preeclampsia is a serious disorder affecting nearly 3% of all pregnancies in the Western world. It is associated
with hypertension and proteinuria, and several lines of evidence suggest that the renin-angiotensin system (RAS) may be
involved in the development of hypertension at different stages of a preeclamptic pregnancy. In this study, we developed
rapid genotyping assays on the LightCycler instrument to allow the detection of genetic variants in the renin gene (REN) that
may predispose to preeclampsia. The method is based on real-time PCR and allele-specific hybridization probes, followed by
fluorescent melting curve analysis to expose a change in melting temperature (Tm). Ninety-two mother-father-child triads (n =
276) from preeclamptic pregnancies were genotyped for three haplotype-tagging single nucleotide polymorphisms (htSNPs)
in REN. All three htSNPs (rs5705, rs1464816 and rs3795575) were successfully genotyped. Furthermore, two unexpected
nucleotide substitutions (rs11571084 and rs61757041) were identified within the selected hybridization probe area of rs1464816
and rs3795575 due to aberrant melting peaks. In conclusion, genotyping on the LightCycler instrument proved to be rapid
and highly reproducible. The ability to uncover additional nucleotide substitutions is particularly important in that it allows the
identification of potentially etiological variants that might otherwise be overlooked by other genotyping methods.
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1. Introduction
Preeclampsia is a heritable complication affecting
nearly 3% of all pregnancies in Western populations [1].
Although the etiology remains to be elucidated, re-
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duced placental perfusion, oxidative stress, activa-
tion of thrombosis and the renin-angiotensin system
(RAS) are probably involved at different stages of a
preeclamptic pregnancy [2–5]. Family studies have
shown that genetic factors contribute to the develop-
ment of preeclampsia, but the exact mechanism is still
unknown despite extensive studies [6–8]. The presence
of renin (REN) in the placenta indicates a local synthe-
sis and suggests that REN may be involved in the reg-
ulation of maternal blood pressure [9,10]. Therefore,
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analysis of the gene coding for REN might contribute
to an improved understanding of the underlying causes
of preeclampsia.
A wide range of genotyping techniques have been
described over the years, including gel-based restric-
tion fragment length polymorphism (RFLP) [11,12],
“closed tubes” assays such as the 5’ fluorogenic nu-
clease assay (TaqMan assay), single-base extension
(minisequencing), PyrosequencingTM, and amplifica-
tion refractory mutation system (ARMS) [12]. Some
genotyping techniques combine real-time PCR with
continuous fluorescence monitoring during amplifica-
tion; an example is the LightCycler instrument, which
uses fluorescence resonance energy transfer (FRET)
and real-time PCR. This technology quantifies an en-
ergy transfer between oligonucleotide fluorophores la-
beled with different dyes. The donor fluorophore is la-
beled at the 3’-end with Fluorescein (FL), while the oth-
er probe labeled at the 5’-end (LC-Red 640 or LC-Red
705) serves as an acceptor. If there is a mismatch be-
tween the target DNA and the hybridization probes, the
melting temperature (Tm) will tend to decrease com-
pared with a perfectly matched probe. Thus, this tech-
nology is also capable of detecting a particular SNP
within the hybridization probe area as a result of a shift
in Tm [13,14].
Here, we present three rapid and reliable genotyp-
ing assays based on this widely used method on the
LightCycler instrument. As a demonstration, DNA
samples from 92 preeclamptic nuclear families (n =
276) were genotyped for three htSNPs in REN. We also
report on the unexpected discovery of two additional
nucleotide substitutions within the selected hybridiza-
tion probe areas for two of the three htSNPs.
2. Materials and methods
2.1. Biological samples
Ninety-two women who delivered at the Stavanger
University Hospital in Norway in the period January
1993 to December 1995 and who fulfilled the diagnostic
criteria for preeclampsia were included in the study [11,
15]. Umbilical cord blood was collected from delivered
neonates and peripheral blood was drawn from mothers
and fathers post partum [11]. The study was approved
by the Regional Committee for Ethics in Medical Re-
search and the Norwegian Data Inspectorate. Written
informed consent was obtained from the parents. The
present work was undertaken as a part of a larger study
examining genetic risk factors for preeclampsia [16].
2.2. SNP selection and DNA extraction
A 40 kb-long region containing REN on chromosome
1q32 (NT 004487.18) was downloaded from HapMap
(http://www.hapmap.org)and imported into Haploview
v.3.0 [17] for the selection of htSNPs and the evaluation
of marker metrics. Three htSNPs on chromosome 1
(rs5705, rs1464816, and rs3795575) were chosen using
the “pairwise tagging” algorithm. All nucleotide posi-
tions are according to the National Center for Biotech-
nology Information (NCBI) assembly 34 of the human
genome (Table 1). To capture the genetic variation
encompassing REN, we used a minor allele frequency
(MAF) cut-off of at least 10% and an r2 greater than
0.8 for linkage disequilibrium within haplotype blocks.
Genomic DNA from 276 samples was extracted using
the QIAamp DNA Blood Mini Kit (Qiagen, Hilden,
Germany).
2.3. PCR primers and hybridization probes
PCR primers and hybridization probes were de-
signed and synthesized by TIB MOLBIOL (Berlin,
Germany). Details are provided in Table 1.
2.4. Genotyping
To genotype rs5705, rs1464816 and rs3795575,
three separate real-time PCR reactions were performed
followed by fluorescent melting curve analyses on
the LightCycler 2.0 instrument (Roche Diagnostics,
Mannheim, Germany). The reaction mixtures con-
tained 2.5 µL of DNA (approximately 10–50 ng),
4 µL of LightCycler FastStart DNA MasterPLUS
HybProbe (Roche Diagnostics), PCR primers, hy-
bridization probes and sterile water to a final volume of
10 µL. Asymmetric PCR conditions were used. PCR
primers and hybridization probes were added at the fol-
lowing concentrations: for rs5705, 0.2 µM RENe2S,
0.4 µM RENe2A, 0.2 µM sensor C, and 0.4 µM An-
chor REN; for rs1464816, 0.2 µM RENi4S, 0.4 µM
RENi4A, 0.2 µM Sensor wt and 0.4 µM of Anchor
REN; and, finally, for rs3795575, 0.2 µM RENi8A, 0.5
µM RENi8S, 0.2 µM REN mut and 0.4 µM of REN LC.
Cycling conditions were 95◦C for 10 min, followed by
45 cycles of 95◦C for 5 s, 52◦C, 56◦C and 58◦C for
10 s for rs5705, rs1464816 and rs3795575 respectively,
then 72◦C for 15 s, with a ramp rate of 20◦C/s. Melt-
ing curve analysis was performed as follows: 95◦C for
10 s, cooling to 55◦C and 45◦C for 30 s each, 40◦C
for 2 min, then heating to 75◦C (0.2◦C/s). Thirty pa-
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Table 1
PCR primers and hybridization probes used for genotyping REN
SNP Nucleotide Alleles PCR primers (5’-3’) Hybridization probes (5’-3’)∗∗
position∗
rs5705 202397809 A/C RENe2S: CAAGAGAATGCCCTCAATCC Sensor C: ATGAAGAGGCTGACCCTTGGC-FL
RENe2A: CAAGCACTCACGTCCATGTAG Anchor REN: 640-ACACCACCTCCTCCGTGATCCTCACC-p
rs1464816 202395477 G/T RENi4S: GCTTTTCTTTTGCTGCTTGG Sensor wt: TGCAGGGTTGAGGCAATAC-FL
RENi4A: TCCTTGGTTGGAATCTGGTC Anchor REN: 640-CTTACCCCGATTTCTGTACCCTGGA-p
rs3795575 202391712 C/T RENi8S: AAGAAGCCAAAGAGGGAAGG REN mut: GCCTTCTTGAGTATGGAAGACATCTCAGC-FL
RENi8A: GAAAGAGATGTCGGGGAGTG REN LC: 640-GACAAGGAGTCCTGCGCTGGTGGC-p
∗Nucleotide positions according to the National Center for Biotechnology Information (NCBI) human assembly 34.
∗∗The position of the polymorphic site is underlined.
Table 2
Genotype distribution of rs5705, rs1464816 and rs3795575 in the human renin
gene (REN) among 92 preeclampsia mother-father-child triads
SNP Genotype Count (%) T◦mC (± SD)∗ ∆ T◦mC
rs5705 A/A 217 (78.6) 58.4 (0.24)
A/C 59 (21.4) 58.4 (0.24) and 66.4 (0.23) 8.2
C/C 0
rs1464816 G/G 112 (40.6) 63.0 (0.40)
G/T 139 (50.4) 63.0 (.040) and 53.1 (0.44) 10.1
T/T 25 ( 9.0) 53.1 (0.44)
rs3795575 C/C 212 (76.8) 65.0 (0.38)
C/T 64 (23.2) 65.0 (0.38) and 70.0 (0.27) 5.1
T/T 0
Tm, melting temperature; (∆Tm; difference in Tm between the wild-type
and mutant genotype).
∗Mean Tm± standard deviation.
tient samples, one positive (heterozygous target) and
one negative (no-template) control (n = 32) were ana-
lyzed simultaneously. All samples (276 in total) were
analyzed in duplicate. The wild-type and mutant geno-
types were differentiated by their characteristic melting
peaks, which were generated by plotting the negative
derivative of the fluorescence signal with temperature
versus temperature (T) [(-dF/dT) versus T].
2.5. Sequencing
To assess genotyping consistency, DNA from 30 ran-
domly selected individuals was sequenced for each ht-
SNP (PCR primers are provided in Table 1). Ampli-
fication products were electrophoresed on 2% agarose
gel and visualized by ethidium bromide staining. PCR
fragments were purified using QIAquick PCR Pu-
rification Kit (Qiagen) followed by cycle sequencing
using ABI PRISM BigDye Terminator v1.1 Cycle
Sequencing Kit (AB Applied Biosystems, Foster City,
CA, USA) according to the manufacturer’s recommen-
dations. Finally, the sequencing reactions were cleaned
using Centri-Sep spin columns (Princeton Separations,
Inc, Adelphia, NJ) according to the manufacturer’s in-
structions and analyzed on an ABI PRISM 310 Genet-
ic Analyzer instrument (AB Applied Biosystems). Re-
sulting sequences were aligned in BLAST (http://blast.
ncbi.nlm.nih.gov/Blast.cgi) for confirmation.
3. Results
DNA samples from preeclamptic women, their part-
ners and children (276 subjects in total) were genotyped
for three htSNPs in REN. Each of the htSNPs showed a
clear difference in Tm between the wild-type and mu-
tant genotype (between 5.1◦C and 10.1◦C). All three
genotyping assays were performed in duplicate and no
inconsistencies between the genotypes were observed.
The results are summarized in Table 2. When geno-
types from the LightCycler analysis were compared
with the results of DNA sequencing in a random set of
30 patient samples, identical genotypes were obtained
for each htSNP.
During fluorescent melting curve analysis, unusu-
al melting peaks around rs1464816 (Fig. 1) and
rs3795575 (Fig. 2) were observed. For rs1464816,
seven of the patient samples revealed atypical melting
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Fig. 1. Typical melting peaks obtained after genotyping rs1464816 by the LightCycler instrument. Patients carrying the homozygous mutant
T/T genotype revealed one single melting peak with a Tm of 53.1◦C (green), whereas those with the wild-type G/G genotype revealed a single
peak with a Tm of 63.0◦C (red). Heterozygous carriers with the T/G genotype revealed two melting peaks (black), one at 53.1◦C and the other
at 63.0◦C. Atypical melting peaks are shown in blue and pink, with a Tm of 61.1◦C. A no-template control is shown in dark green. The DNA
sequence (reverse direction) is from a patient who is heterozygous A/C for rs1464816 (blue arrow) and simultaneously heterozygous G/A for
rs11571084 (highlighted by the black arrow).
peaks, with a Tm of 61.1◦C, 1.9◦C ± 0.12 (mean ±
SD) lower than the Tm of the wild-type genotype G/G
(Fig. 1). For rs3795575, 16 samples revealed atyp-
ical melting peaks, with a Tm of 59.8◦C, 5.2◦C ±
0.28 lower than the Tm of the wild-type genotype C/C
(Fig. 2). To confirm that the atypical melting peaks
were not due to error,we reanalyzed DNA from patients
exhibiting atypical melting peaks. Identical results
were observed. When we sequenced these samples,
additional nucleotide substitutions were discovered in
the hybridization probe areas; namely, rs11571084
[A/G] (Chr1: 202395455), 22 nucleotides upstream of
rs1464816, and rs61757041[A/G] (Chr1: 202391716),
4 nucleotides downstream of rs3795575, respectively.
4. Discussion
Detection of etiologically relevant SNPs is a power-
ful diagnostic test for inherited disorders. In this study,
we developed genotyping assays for REN by allele-
specific hybridization probes followed by fluorescent
melting curve analysis on the LightCycler instrument.
The technique proved to be rapid and reliable. Thir-
ty patient samples, together with positive and negative
controls, were genotyped in less than an hour, and the
results were highly reproducible when cross-checked
against direct sequencing.
Genotyping on the LightCycler instrument is par-
ticularly advantageous compared with other traditional
genotyping techniques [11,12] in that it does not re-
quire any post-PCR sample processing, no hazardous
reagents are involved, and the entire reaction takes
place in a close-tube system, which minimizes the risk
of contaminations. All these factors are important
to consider in a moderate-sized lab-facility. Further-
more, the unanticipated detection of rs11571084 and
rs61757041 within the hybridization probes areas de-
signed for rs1464816 and rs3795575 demonstrates the
ability of the technique to distinguish patient samples
with additional nucleotide substitutions. Samples from
patients carrying these unexpected nucleotide substitu-
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Fig. 2. Typical melting peaks obtained after genotyping rs3795575 by the LightCycler instrument. Patients with the wild-type C/C genotype
revealed a single melting peak with a Tm at 65.0◦C (red) and patients with the heterozygous C/T genotype revealed two melting peaks, one at
65.0◦C and the other at 70.0◦C (blue). An atypical melting peak with Tm at 61.1◦C is shown in green, and the no-template control is shown in
black. The DNA sequence (forward direction) is from a patient who is homozygous wild-type C/C for rs3795575 (blue arrow) and simultaneously
heterozygous A/G for rs61757041 (highlighted by the black arrow).
tions (rs11571084 and rs61757041) affected our geno-
typing assays by generating atypical melting peaks.
It is possible to accommodate known nucleotide sub-
stitutions located close to the actual SNP in the assay
design by modifying the location or the size of the hy-
bridization probe sequence [18,19]. Alternatively, this
can be achieved by using a “masking technique”, in
which hybridization probes are designed as a “mask”
over a non-target sequence. That is, an artificial mis-
match with all possible alleles adjacent to the mutations
is created as described by Margraf and co-workers [19].
In our case, however, all three genotyping assays were
designed without prior knowledge of rs11571084 and
rs61757041.
The impact of these two nucleotide substitutions on
the development of preeclampsia is unknown and fu-
ture studies are warranted to determine the frequen-
cy and association of these variants with disease de-
velopment and progression. The sample size clear-
ly needs to be increased in order to gauge the impact
of these additional nucleotide substitutions on the risk
of preeclampsia. According to the dbSNP database
(www.ncbi.nlm.nih.gov/sites/entrez), two other SNPs
(rs11571116 and rs61757042) have recently been re-
ported in the vicinity of rs1464816 and rs3795575.
rs11571116 has not been typed in the CEPH sample of
Northern-European origin, while data for rs61757042
have not yet been released in all the HapMap test pop-
ulations (www.hapmap.org).
Several diagnostic assays have been developed on the
LightCycler instrument, enabling the identification
of genotypes by characteristic melting peaks and Tm
shifts [20–22]. Some of these well-established diag-
nostic assays have reported atypical melting peaks due
to the presence of new nucleotide substitutions in the
hybridization probe area beside those the assays were
originally designed for. These additional nucleotide
substitutions have shown varying clinical effects [23–
26]. Atypical melting peaks are usually detected by
Tm shifts of 5–6◦C or higher and may therefore be eas-
ily overlooked if the Tm shifts are less than 1◦C, or if
there is an overlap in Tm [27,28]. However, if the hy-
bridization probe area is particularly ambiguous or has
not been reported in the public databases, validation
with an alternative method and/or direct sequencing of
patient samples in diverse populations is warranted.
In conclusion, genotyping using the LightCycler
instrument allows highly specific detection of SNPs in
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the targeted DNA sequence. In particular, the discovery
of new nucleotide substitutions within the hybridization
probe area represents a significant advance over oth-
er conventional genotyping platforms. This, coupled
with relatively low cost and minimum hands-on time,
makes the LightCycler technique particularly attrac-
tive for cost-effective and rapid genotyping in smaller
lab-facilities.
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